Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). Our antibody therapy, RZ358 (ersodetug), is designed to treat…
Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and…
Cookies?
A session cookie keeps you signed in. If you accept, we also use analytics cookies (Google Analytics and PostHog) to understand usage. Learn more
We couldn't check your fit for this role — add a CV to your profile to see it next time.